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THE ASSOCIATION BETWEEN SPIRITUALITY AND DEPRESSION IN
PARKINSON’S DISEASE. Kwabena L. Blankson and Benjamin R. Doolittle.
Department of Internal Medicine, Yale University, School of Medicine, New Haven, CT.

Spirituality has been an important coping mechanism for individuals struggling with a
chronic illness. The objective of this pilot study is to correlate spirituality and depression
in patients with Parkinson’s disease (PD). Individuals with PD belonging to support
groups were solicited via mail and asked to complete a questionnaire consisting of 3
parts: 1) basic patient information, 2) the Zung depression scale, and 3) the SIBS
(Spiritual Involvement and Beliefs Scale). Among our sample (n=20), most were married
(90%) and considered themselves spiritual (80%). 65% were depressed based on Zung
Self-Depression Scale scores. A model based on non-linear relationships (quadratic
model) revealed a significant correlation (p<0.05) between SIBS and depression scores,
with a parabolic distribution of data points: patients with lower and higher spirituality
scores had lower depression scores. Mid-range spirituality scores were associated with
higher depression. The Existential/Meditative domain of the SIBS was negatively
correlated to Zung scores (rs =-0.4927, p<0.05). Using multivariate regression analysis,
our model that included age, gender, marital status, income, severity of PD, years with
PD, and SIBS scores accounted for 92% of the variance of depression (R:=0.92, p<0.05),
with gender and years with PD as the only significant variables (p<0.05). We conclude
that spirituality is associated with depression in PD in a very specific way, and that
healthcare providers should address a patient’s spirituality as an adjunct to
pharmacotherapy in the treatment of depression in PD.
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INTRODUCTION

Parkinson’s disease: Diagnosis and Clinical Features

Parkinson’s disease (PD) is a neurodegenerative disease that affects 3% of
people over the age of 65 [1]. It affects over 1 million people in North America.
Commonly underdiagnosed and misdiagnosed, PD is projected to pass cancer
as the second most common cause of death among the elderly by 2040 [2],
Mortality among PD patients is 2 to 3 times that of age-matched controls, and
dementia occurs 6.6 times more frequently in elderly persons with PD
compared to elderly controls [3-5]. The gold standard for diagnosis is not
clinical but neuropathophysiologic, though no specific pathophysiologic
hallmark exists to consistently make the diagnosis.
PD is characterized by loss of an assortment of neurons, particularly
dopaminergic neurons in the pars compacta of the substantia nigra, small
cortical neurons, catecholinergic and serotonergic brain stem nuclei, and
hypothalamic neurons, to name a few. As dopamine is essential for the
coordination of muscles and movement, there are many motor manifestations
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of PD, including tremor, rigidity, bradykinesia and gait disturbance. Treatment
with dopamine (specifically levadopa) ameliorates the majority of these motor
symptoms [6, 7], The presence of cytoplasmic inclusion bodies known as Lewy
bodies is another pathophysiologic feature of PD, although Lewy bodies are
found in other neurodegenerative diseases. The mechanism of Lewy body
formation, as well as its role in the pathogenesis of PD, is poorly understood.
The clinical syndrome was first described by James Parkinson in 1871 [8].
At the time, Parkinson may not have been fully aware of the emotional and
psychological aspects of the disease he described as “shaking palsy.” Even
today, health professionals continue to struggle to understand these non¬
movement related aspects of PD which include depression, dementia, anxiety,
weight loss, sleep disturbance, and sexual dysfunction.

Depression in Parkinson’s Disease

Studies have estimated the prevalence rate of depression of PD patients to
range between 25-40% [9-12]. In fact, depression is more common in PD as
compared to those with a comparable disability[13]. In one particular study,

3

Menza et al. showed that PD patients had higher depression and anxiety
scores than those with equal amounts of disability [14]. The authors concluded
that depression in PD must go beyond a reactive psychological response and
that there must be something intrinsic to PD that leads to higher depression
scores. In this same study, depression was significantly correlated with a
variety of variables such as Sevadopa dose, length of illness, disability score,
and the harm avoidance personality trait. The harm avoidance personality trait
(and other personality traits affected in PD) is thought to be mediated by the
serotonin, and its correlation with depression scores lead to the authors’
suggestion that depression in PD is mediated more by serotonin, given
dopamine’s poor track record in improving depression in PD.
Clearly, the cause of depression in PD is likely multifactorial, mediated by
both neurologic and psychological factors. Causes include but are not limited
to changes in brain function caused by loss of dopaminergic neurons,
serotonin and the unique and potentially frustrating challenges of living with
PD [15], Mood changes can be directly attributed to changes brought upon by

medication, most specifically the motor “on-off’ phases associated with taking
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dopamine. Depression is less during an “on” state, when a PD patient’s
levadopa is working well and bradykinesia and rigidity are ameliorated as
compared to an “off” state, when the beneficial effects of levadopa have worn
off and depression is increased [16]. One recent study has showed that
depression in PD is an important predictor of mortality [17]. Advancing
disease state, recent disease deterioration, occurrence of falls, and patients’
perceptions of handicap have all been associated with depression in PD [18,
19].

Traditionally, treatment of depression has centered primarily on
pharmacotherapy and sometimes psychotherapy as adjuvant treatment.
Amongst those with PD, one study estimated that only 26% of PD patients
received pharmacotherapy for treatment of depression [20]. Selective
serotonin uptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) were
the most utilized drugs for treatment of depression in this study that surveyed
49 neurologists who cared for over 20,000 PD patients. And while the use of
antidepressants appear to be widespread in PD, there have been very few
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randomized controlled trials of antidepressants specifically in PD, none with
definitive conclusions [21-23]. Clinicians continue to treat PD patients with
antidepressants likely due to perceived general effectiveness and lack of other
proven therapies. The question remains: why are PD patients treated with
antidepressants if no sufficient data exists in favor of the effectiveness or
safety of these drugs in PD [24], even when potential risks include inducement
of parkinsonian symptoms, orthostatic hypotension, and serotonin syndrome?
And what other potential therapies exist for treatment of depression in PD?

Spirituality and Depression in PD

Several studies which correlate religious commitment and mental health
show a positive association between the two [25]. Larson et al. conducted a
review of 2 leading psychiatric journals, compiling all the studies on spirituality
and mental health over an 11 year period [26], 84% of those studies showed a
positive association between spirituality and mental health. Many populations,
from burn victims to urban poor, have shown that increased religious
commitment correlated with decreased depression [27-29]. Doolittle et al.
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surveyed 122 adult patients in an urban primary care clinic and found that
spirituality and depression scores were negatively correlated; high spirituality
scores predicted lower depression scores [29]. Cooper et al. found that
African-American patients rated spirituality as important to depression care 3
times more than whites did.
There have, however, been no studies correlating spirituality and mental
health specifically in PD. This finding can be partly explained by the poor
understanding of the cause of depression in PD. Schrag et al. used the WHO
model of impairment, disability and handicap to assess the factors that might
contribute to depression in PD [18]. Using various instruments (Beck
Depression Inventory, Hoehn and Yahr Disease Severity Scale, Schwab and
England Disability Scale, Unified Parkinson’s Disease Rating Scale, and the
Mini-Mental State Examination), the authors ascertained that higher
depression scores were associated with advancing disease severity, recent
disease deterioration, and occurrence of falls. They also found that patients’
perception of physical handicap more strongly influenced depression than
actual physical handicap.
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Leentjens and Verhey articulate the conceptual challenge of depression
and Parkinson’s disease, concluding that depression associated with PD
should be considered intrinsic to the disease, not stemming solely from either
neurobiological or psychological etiologies [30], One issue that seems to
confound the diagnosis of depression in PD is the overlapping
symptomatology and pathophysiology. Depressed individuals and PD patients
may both exhibit decreased appetite, sleep disturbances, psychomotor
retardation and mental slowing. Both groups also undergo changes in
neurochemistry, specifically in the serotonergic system. One can foresee the
diagnostic challenge this poses to healthcare professionals: Is the patient
exhibiting parkinsonism or depression, or is the Parkinson’s disease itself
causing the depression? Leentjens and Verhey suggest an interdisciplinary
treatment team for depression in PD including neurologist, psychiatrist and
psychologist.
A thorough MEDLINE literature review yielded no studies of spirituality and
depression in the context of Parkinson’s disease. As a population, PD patients
warrant study as their prevalence of depression is higher than the general
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population, and the cause of their depression is clearly not based solely upon
neurochemical brain changes. Pharmacotherapy only addresses one of the
many potential causes of depression in PD patients. What role might
spirituality play in the treatment or experience of depression in Parkinson’s
disease?

HYPOTHESIS
There are unique challenges to the question of how to address depression
in PD, and the purpose of this study is to explore the relationship between
spirituality and depression in PD. We hypothesize that there will be a negative
correlation between Zung depression scores and spirituality scores as
measured by the Spiritual Involvement and Beliefs Scale (SIBS): patients with
greater spirituality will be less likely to be depressed.
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METHODOLOGY
Design
The study consisted of administering a survey containing three parts: 1)
basic patient information, 2) Zung depression scale [31] , and 3) the SIBS
(Spiritual Involvement and Beliefs Scale) [32]. Parkinson’s patients from
across New England were solicited via mail.
Subjects were identified via internet search through Parkinson’s support
groups in the New England area. Using the website www.parkinson.org,
Parkinson’s Disease support groups within 200 miles of New Haven were
solicited through e-mail, letter, or phone. The support group coordinators were
then asked to identify the members in their groups interested in participating in
the study. Once identified, these subjects received surveys directly from the
group coordinators (who received the surveys from the research team via mail).
Participation in the study was voluntary, anonymous, and confidential. The
study was approved by the Yale University School of Medicine Human
Investigations Committee in October 2004.
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Survey Instruments

The survey contained three parts: 1) basic demographic information (e.g.
age, gender, marital status) and a few general questions about health, religion
and spirituality (e.g. severity of Parkinson’s disease, religious affiliation, “do
you consider yourself religious,” “do you consider yourself spiritual”) 2) the
Zung depression scale and 3) the Spiritual Involvement and Beliefs Scale
(SIBS) (See Appendix).
The Zung depression scale is a validated 20 question self-administered
survey that assesses depression symptoms such as insomnia, weight loss,
anhedonia, and irritability [31]. Questions are positively or negatively phrased,
e.g. “My mind is as clear as it used to be,” “I feel down-hearted and blue.”
Answers are scored on a 4 point Likert scale, with 4 representing the least
favorable response. The raw score (the summation of point totals from the 20
questions) is converted to a ‘Self-rating Depression Scale (SDS) index’, a
depression-judging variable which is then interpreted against established
grouping parameters. An SDS index of less than 50 is considered normal, 50
to 59 mild depression, 60 to 69 moderate depression, and greater than 70
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severe depression. As a predictor of depression, the Zung scale is widely used
and its validity is well-established in the literature [33, 34].
The Spiritual Involvement and Beliefs Scale was designed by Robert Hatch
and collaborators in 1998 as an instrument to assess spiritual status [32],
Unlike other instruments before it, the ability of the SIBS to cross religious
traditions is one of its strengths. Perspectives from multiple religions were
solicited and key cross-religion principles were identified and stated in neutral
language, avoiding catch words or phrases from particular religious or spiritual
groups. The SIBS focus on action and not just belief gives it the ability to be a
broader measurement of a person’s spirituality, a feature that separates it from
other available instruments. This validated scale is comprised of 26 items
scored on a 5 point Likert scale. In addition to an overall score, the items can
be clustered into 4 different domains/factors, each with particular content
(Table 1). Factor 1, labeled External/Ritual, is comprised of items that pertain
to spiritual beliefs or rituals that are consistent with belief in a higher power.
Factor 2, labeled Internal/Fluid, contains items related to an evolving or
growing internal belief system. Factor 3, labeled Existential/Meditative,
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contains items dealing with existential and meditative issues. Lastly, Factor 4,
labeled Humility/Personal Application, deals with the application of spiritual
principles to daily life.

Table 1. The Four SIRS Factors/Domains
DOMAIN

Sample Questions

Factor 1

Extemal/Ritual

“I believe in a higher power”

Factor 2

Intemal/Fluid

“I probably will not reevaluate my religious beliefs”

Factor 3

Existential/

“I prayed/meditated/participated in spiritual activities

Meditative

with another person x times last week”

Humility/Personal

“When I wrong someone, I make an effort to

Application

apologize”

Factor 4

Analyses

Raw data from completed questionnaires was compiled into a Microsoft
Excel Database, and statistical analyses were conducted with JMP4 Statistical
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Software. Several statistical methods were utilized. The SDS indices (obtained
from the Zung) and the SIBS scores were compared via the Spearman’s rank
correlation coefficient. Additional comparisons via Spearman’s rank correlation
coefficient included Zung SDS indices and SIBS domains (Factors 1-4). Paired
t tests were performed to compare Zung SDS indices against individual SIBS
items divided into “high” and “low” spirituality categories, “high spirituality”
defined as answers of “agree” and “strongly agree” and “low spirituality” as
answers of neutral or below. Additionally, specific demographic factors and
variables such as years with PD and severity of PD were compared to Zung
SDS indices and SIBS domains via paired t tests.

Chi square tests between depression and demographic attributes were also
conducted. Multivariate regression analysis was performed to assess the
impact of demographic variables, self-assessment of religiosity and spirituality,
socioeconomic status, severity of PD, and years with PD.

14

Results
One hundred and twenty surveys were mailed to support groups across the
New England area. To date, twenty completed surveys have been received
and processed. Since surveys were distributed to support group leaders based
on estimates of maximum support group attendance, the number of surveys
actually distributed is unknown.
Table 2 summarizes the demographic data. The average age of
respondents was 68 years old. 75% were male. The majority was married
(85%), and only a few (10%) lived alone. More than half of the respondents
(60%) lived with someone who helped them with their activities of daily living,
and 90% lived with someone who helped them cope with their disease.
Average income ranged from $40,000 to $60,000. In terms of symptom
severity, most felt their symptoms were moderate (with none, mild, and severe
being the other choices). The average length of Parkinson’s diagnosis was 10
years.
Respondents came from variety of religious traditions including Roman
Catholic, Judaism, and Protestant. 55% answered “yes” to the question “Do
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you consider yourself a religious person?” while 80% answered “yes” to “Do
you consider yourself a spiritual person?” When asked to rank how important
spirituality was in coping with disease on a scale of 1-10, the mean response
was 7. Ranking on this scale was positively correlated with the validated
measure of spirituality, the SIBS, specifically in the external (Factor 1) and
internal (Factor 2) domains (rs =+0.5584, p<0.05, (rs =+0.5934, p<0.05,
respectively). The suggestion is that for those who use spirituality in coping
with their PD, external rituals (like weekly prayer, participating in spiritual
activities with other people) and an evolving belief system are the primary
spiritual avenues of coping with PD.
The average Zung SDS index was 55 (sd +/- 10), meaning that the average
respondent was mildly depressed. The prevalence of depression (as
measured by Zung SDS scores) among respondents was 65%, much higher
than the national estimates of depression in the general population [35] (10%)
and also higher than estimates of depression in the Parkinson’s population
(25-40%) [5-8]. One unexpected finding was the negative correlation between
depression scores and years with PD (rs =-0.5342, p<0.05), suggesting that
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the individuals who had lived with PD for a longer period of time were less
depressed.
Table 2. Demographic Characteristics of 20 Survey Respondents
with Parkinson's Disease
Characteristic
Age, mean +/- SD

Value
67.6+/- 10

Gender
Male

75%

Marital Status
Married
Ethnicity/Race
Caucasian
Hispanic
Other/No response
Annual Income
<$20,000
$20-40,000
$40-60,000
$60-80,000

90%
60%
10%
30%
5%
25%
35%
10%
25%

>$80,000
Years lived with PD

9.7

Parkinson’s Severity
Mild
Moderate/Severe

40%
60%

Answered ‘Yes’ to the question:
Do you live with someone who helps you
cope with disease?
Answered ‘Yes’ to the question:
Do you consider yourself a religious
person?
Do you consider yourself a spiritual person?
Average score in response to
On a scale of 1-10, how important is your
support group in coping with your illness?

90%

55%
80%
5.8 +/- 2.3

Average score in response to
On a scale of 1-10, how important is your
spirituality in coping with your illness?

6.6 +/- 3.0

Religious Affiliation
Roman Catholic

25%

Protestant
Jewish

5%

No response/other

40%

Zung Self Depression Scale Categories
Normal
Mild depression
Moderate depression
Severe depression

30%

35%
25%
35%
5%
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In spite of specifically targeting support groups, we paradoxically recruited
a small number of respondents (2) who did not participate in support groups.
Of the vast majority who did, 83% felt that their support group helped them
cope with their illness. Amongst support group attendees in this study, 61%
qualified as depressed. Spearman’s rank correlation coefficient between Zung
scores and responses to the question “On a scale of 1-10, how important is
your support group in coping with your illness?” (rs =+0.4841, p<0.05)
corroborate the above data’s suggestion that individuals who choose to attend
PD support groups are depressed and may do so to help cope with their PD
and depression (See Table 2 for correlation coefficients). Spearman’s rank
correlation coefficient showed positive correlation between responses to the
question “Does your support group help you cope with your illness?” and “On a
scale of 1-10, how important is spirituality in coping with your illness?” (rs
=+0.4965, p<0.05). This relationship reflects that respondents who reported
that support groups helped them cope also reported received support from
their spirituality.

Spearman’s rank correlation coefficient comparing SIBS scores to
depression scores (Zung SDS indices) was not significant (rs =-0.2914,
p>0.05), suggesting little linear correlation between spirituality and depression
amongst Parkinson’s patients. Examining the data points on a plot, we tested
a model based on non-linear relationships (quadratic model) and discovered a
significant correlation (R2 =0.41, p<0.05) (Figure 1).The implications of this
parabolic model are that least depressed PD individuals lie at the extremes of
the spirituality spectrum, being either highly spiritual or not spiritual at all.

Figure 1. Bivariate fit of depression scores (SDS index) by SIBS score

One interesting linear correlation was found when comparing Zung scores
to specific spirituality domains (Factors 1-4). While Factors 1,2 and 4 were not
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statistically significant, Factor 3 (Existential/Meditative) was negatively
correlated to Zung scores (rs =-0.4927, p<0.05), suggesting that the less
depressed a person was, the more he or she identified with existential and
meditative methods of spirituality. Specific questions posed in this domain
were, “I can find meaning in times of hardship,” “My life has a purpose,”
“Prayers do not really change what happens,” and questions on the number of
times a person prayed last week, meditated last week, or participated in
spiritual activities with another person last month.

Table 2. Nonparametric Spearman's Rank Correlation Coefficients between Variables
Spearman’s
Rho
-0.3385

Probability
0.1694

SIBS EXTERNAL domain

-0.1962

0.4353

SIBS INTERNAL domain

-0.2912

0.2411

Zung score (SDS index)

SIBS EXISTENTIAL domain

-0.4951

0.0367

Zung score (SDS index)

SIBS HUMILITY domain

-0.3027

0.2221

age

-0.0431

0.8652

Variable

by Variable

Zung score (SDS index)

SIBS score (total)

Zung score (SDS index)
Zung score (SDS index)

Zung score (SDS index)

-0.197

0.4333

-0.4834

0.0421

patient’s rank of utility of spirituality in coping with illness

0.1336

0.5973

Zung score (SDS index)

patient's rank of utility of support group in coping with illness

0.5038

0.0466

SIBS score (total)

age

-0.2077

0.3934

SIBS score (total)

severity of PD

0.1401

0.5673

SIBS score (total)

number of years with PD

SIBS score (total)

patient's rank of utility of spirituality in coping with illness

0.2384
0.4597

0.3256
0.0500

SIBS score (total)
SIBS EXTERNAL
domain

patient's rank of utility of support group in coping with illness

-0.3747

0.1528

0.5934

0.0094

0.5584

0.016

Zung score (SDS index)

severity of PD

Zung score (SDS index)

number of years with PD

Zung score (SDS index)

patient's rank of utility of spirituality in coping with illness

SIBS INTERNAL domain
patient's rank of utility of spirituality in coping with illness
*Significant correlations indicated by gray shading.
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Paired t tests comparing the depressed and non-depressed to specific
responses on items of the SIBS revealed significant differences only in
responses to questions 11,20, and 23. The questions were as follows:
11. My spiritual beliefs continue to evolve.
20. When I wrong someone, S make an effort to apologize.
23. I examine my actions to see if they reflect my values.
The trend of responses across the three questions was that respondents with
high Zung scores answered these questions on the lower end of the scale
(“neutral”, “disagree”, “strongly disagree”) as compared to respondents with
low Zung scores.
Chi square analysis showed no significant difference between depression
and any of the demographic factors (i.e.. age, gender, income, etc.). While
other studies have suggested severity of illness is associated with worsening
depression, this study showed no significant difference between t tests
comparing Zung scores to Parkinson’s severity. Additionally, there was no
significant different between SIBS scores and Parkinson’s severity.
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Using multivariate regression analysis, our model that included age, gender,
marital status, income, severity of PD, years with PD, and SIBS scores
accounted for 92% of the variance of depression (R2=0.92). Only gender and
years with PD were significant variables (p<0.05).

Discussion
This pilot study is the first to specifically address the association between
spirituality and depression in Parkinson’s disease (PD). As prevalent as
depression is amongst individuals with PD, few studies have specifically
examined alternatives to pharmacotherapy as treatment for depression in PD.
As previous studies of spirituality and depression in other populations had
shown, we expected to see a negative correlation between depression scores
and SIBS scores (e.g. lower depression scores are associated with high
spirituality scores). And though we did not find the linear relationship we
expected, the parabolic model we discovered (p«0.05) poses intriguing
questions about the interplay between spirituality and depression in PD. It
appears that the least depressed individuals were either extremely spiritual or
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not very spiritual at all when compared to the depressed individuals. Why
might this dichotomy exist? Perhaps those who are very spiritual are “spiritual
enough” to combat depression effectively, and those not spiritual at ail are
highly self-reliant and similarly able to fight depression. Does the “half¬
heartedness” of those in the middle prevent them from being able to battle
depression? Perhaps an appropriate analogy would be patients who are given
a course of antibiotics to treat a particular disease. Cure can be achieved by
full compliance or even possibly by complete non-compliance, allowing the
body’s immune system to fend for itself. But partial compliance (Le., taking the
medicine until you feel better or only when you feel like it) may lead to only a
partial cure and an illness relapse or development of antibiotic resistance.
Spirituality may require “full compliance.”
With the parabolic model being so significant, it is no surprise that we found
few linear correlations between depression and spirituality. We looked
specifically at the four domains captured within the SIBS and did find a
negative linear correlation between the existential/meditative domain and
depression scores, the implication being that non-depressed individuals (low
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Zung scores) seemed to utilize existential and meditative methods of
spirituality. In light of the questions under that domain (“I can find meaning in
times of hardship”, “My life has a purpose”, questions on the number of times a
person prayed last week, meditated last week), perhaps those who are able to
find meaning in their disease and actively pursue spiritual activities such as
prayer and meditation protect themselves from succumbing to depression.
Why perceived severity of disease and depression were not correlated
remains unclear. As mentioned earlier, the mechanism of depression in
Parkinson’s is poorly understood; perhaps the reason no correlation exists
between severity and depression is the multifactorial nature of depression in
PD. We hypothesize that in early Parkinson’s, depression may be mediated
more by frustration and the initial experience and difficulties of having a
debilitating movement disorder. In late/severe PD, depression may be driven
more by neurochemical factors. Hence, individuals with PD may have
depression over the entire time spectrum they live with the disease; the
reasons for that depression may change over time, making severity irrelevant.
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This study revealed much about the use of support groups amongst
individuals with PD. Most support group attendees were depressed and
believed that their support group helped them cope with their illness. One
small study of a Parkinson’s disease support group showed that group
attendees actively tried to acknowledge and incorporate their illness into their
everyday life, much more so than non-attendees [36]. Could spirituality be the
element that enables support group attendees to achieve this? Our study
showed that using support groups to cope and using spirituality to cope with
PD were highly correlated, and perhaps it is the support group that gives
people the structure by which their spirituality can flourish. A German study
comparing coping strategies between patients with PD, traumatic brain injury,
stroke, and malignant brain tumors showed that patients with PD tended to
cope by searching for religious relief or quest for sense more than the other
groups [37], Armed with this knowledge, healthcare providers for PD patients
could focus on spirituality as a means of helping them cope with their disease.
One of the main flaws in this study stem was the small sample size (n=20),
leaving our data analysis thoroughly underpowered. Based on an alpha of 0.05,
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a power of 80%, and a standard deviation of 9.7 to detect a 10% difference in
the Zung Depression Scale, we calculated that 23 patients would need to
participate. To ensure significance, our goal was to enroll 50 patients. Our
method of solicitation was the most likely culprit for not reaching our
recruitment goal. Though over 120 surveys were mailed to over 10 different
support group leaders, these leaders were sent surveys based on their
maximum estimate of support group attendance (e.g. if their largest
attendance was 20, they received 20 surveys). One support group leader sent
back 5 unused surveys in the mail. A follow-up email and phone call to support
group leaders verified that group cancellations and other logistical problems
(bad weather, infrequent meeting times) had delayed the distribution of some
of the surveys, so we expect to compile and analyze more data over the
course of the next few weeks. Plans for future mailings to interested support
group leaders are currently underway.
Another flaw in our study is the obvious selection bias. Not only were many
individuals with severe disease unlikely to complete the survey, but also
almost all of our respondents attended support groups, and though this does
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not invalidate our results, it certainly prevents us from generalizing our findings
to the entire Parkinson’s population. The kind of individual who might choose
to attend a support group may be different from one who does not. A follow-up
study of non-support group attendees could provide interesting evidence about
the usefulness of support groups in PD.
Support groups may provide a comfort zone for individuals with PD, many
of whom feel stripped by their own bodies of basic human abilities, like that of
displaying facial emotions. “I feel trapped” is a sentiment shared by many in
the Parkinson’s community, whose daily battles with their own bodies daily are
tempered by victories lasting only as long as the last L-dopa dose*. The
frustration forces many to turn inward; but the war on the exterior eventually
weeds its way internally, and the fight for the heart, soul, and mind begin.
When the depression sets in, does it become harder to apologize for wrong
actions, reexamine one’s spiritual beliefs, or review one’s actions in the
context of a personal value system? For the Parkinson’s individual at the
height of depression, the answer may be yes. Spirituality allows the individual

* From personal anecdotes and interactions with many patients with PD.
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to rely on a power higher than his/her self and find meaning, a veritable oasis
in the desert of an incurable disease.
Does spirituality have a future in the treatment of depression in Parkinson’s
disease? Pharmacotherapy will continue to be the primary treatment, but we
hope that healthcare providers will begin to consider a patient’s spirituality as
part of mental and emotional health assessment. It may prove to be an
overlooked but important method of addressing the depression that all too
often accompanies this difficult disease.
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Appendix: Survey Instruments
Spirituality and Depression in Parkinson’s Disease Questionnaire
Please fill out some information about yourself Please do not include your name, as your
answers are confidential.

Part I: Basic Demographic Information
Age_ Gender_

Ethnicity_

Marital Status_

# of children_

Do you live alone? Yes or No
If no, how many people live with you?_ Do they help with your daily activities?_
If no, does anyone help with your daily activities? Yes or No
What is your household income (dollars per year, best guess)?
_less than $20,000

_ $20-40,000 _ $40-60,000

_$60-80,000 _$80-100,000 _more than $100,000
Number of Years you have lived with Parkinson’s Disease:
Please rank the severity of your disease: 1-no symptoms 2-mild

3-moderate 4-severe

Religious affiliation:
Do you consider yourself a religious person? Yes or No
Do you consider yourself a spiritual person?

Yes or No

Does your support group help you cope with your disease? Yes or No
On a scale of 1-10 (1= not important at all 10=extremely important), how important is your support
group in coping with your illness?_
Do you live with someone who helps you cope with your disease? Yes or No
On a scale of 1 -10 (1= not important at all 10=extremely important), how important is your spiritual
life to coping with your illness? _
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Part II: Zung Self-Rating Depression Scale

Please answer the following questions by checking your response.
A large
Little or
Most of
Some of
part of
none of
the time
the time
the time
the time

1.1 feel downhearted, blue and sad
2. Morning is when 1 feel the best
3. 1 have crying spells or feel like it
4. 1 have trouble sleeping through the
night
5. 1 eat as much as 1 used to
6.1 enjoy looking at, talking to, and
being with attractive women/men
7. i notice that 1 am losing weight
8. 1 have trouble with constipation
9. My heart beats faster than usual
10. 1 get tired for no reason
11. My mind is as clear as it used to be
12. I find it easy to do the things 1 used
to do
13. 1 am restless and can’t keep still
14. 1 feel hopeful about the future
15. 1 am more irritable than usual
.
16. 1 find it easy to make decisions

..

.

17. 1 feel that 1 am useful and needed
18. My life is pretty full
19. 1 feel that others would be better off
if 1 were dead
20.1 still enjoy the things that 1 used to

1
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Part III: Spirituality Involvement and Beliefs Scale

Please answer the following questions by checking your response.
Strongly
Agree
1. In the future, science will be able to explain
everything.
2.1 can find meaning in times of hardship.
3. A person can be fulfilled without pursuing an active
spiritual life.
4.1 am thankful for all that has happened to me.
5. Spiritual activities have not helped me become closer
to other people.
6. Some experiences can be understood only through
one’s spiritual beliefs.
7. A spiritual force influences the events in my life.
8. My life has purpose.
9. Prayers do not really change what happens.
10. Participating in spiritual activities helps me forgive
other people.
11. My spiritual beliefs continue to evolve.
12.1 believe there is a power greater than myself.
13.1 probably will not reexamine my spiritual beliefs.
14. My spiritual life fulfills me in ways that material
possessions do not.
15. Spiritual activities have not helped me develop my
identity.
16. Meditation does not help me feel more in touch
with my inner spirit.
17.1 have a personal relationship with a power greater
than myself.
18.1 have felt pressured to accept spiritual beliefs that
I do not agree with.
19. Spiritual activities help me draw closer to a power
greater than myself.
20. When 1 wrong someone, I make an effort to
apologize.
21. When I am ashamed of something I have done, I
tell someone about it.
22.1 solve my problems without using spiritual
resources.
23.1 examine my actions to see if they reflect my
values.
24. During the LAST WEEK, I prayed....
25. During the LAST WEEK, I meditated....
26. During the LAST MONTH, I participated in
spiritual activities with at least one other person....

Agree

Neutral

Disagree

Strongly
Disagree

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0
0

0

0

0

0

0
0

0
0

0
0

0
0
0

0

0

0

0

0

0
0
0

0
0
0

0
0
0

0
0
0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

>10
times

7-9
times

4-6 times

1-3 times

zero
times

>10
times
>15
times

7-9
times

4-6 times

1-3 times

11-15

6- 10

1-5

0
0

1

zero
times
zero
times
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